125
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The Concept of Oligometastatic Disease in Gastric Cancer: Reality or Fiction?

, ORCID Icon, ORCID Icon, &
Pages 135-138 | Received 12 Oct 2021, Accepted 15 Oct 2021, Published online: 10 Dec 2021

References

  • Wang F-H , ShenL, LiJet al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun.39(1), 10 (2019).
  • Brenner H , RothenbacherD, ArndtV. Epidemiology of stomach cancer. In: Cancer Epidemiology (Volume 472).VermaM (Ed.).Humana Press, NJ, USA, 467–477 (2009).
  • Yang D , HendifarA, LenzCet al. Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity. J. Gastrointest. Oncol.2(2), 77–84 (2011).
  • Assi T , ElRassy E, KhazzakaAet al. Characteristics of gastric cancer in Lebanon: a descriptive study from a single institutional experience. J. Gastrointest. Cancer49(1), 21–24 (2018).
  • Jin P , JiX, TianY. Surgical management of oligometastatic disease in gastric cancer. Clin. Res. Hepatol. Gastroenterol.44(5), 638–645 (2020).
  • Ministrini S , SolainiL, CipollariCet al. Surgical treatment of hepatic metastases from gastric cancer. Updat. Surg.70(2), 273–278 (2018).
  • Gadde R , TamarizL, HannaMet al. Metastatic gastric cancer (MGC) patients: can we improve survival by metastasectomy? A systematic review and meta-analysis: Metastatic Gastric Cancer (MGC) Patients. J. Surg. Oncol.112(1), 38–45 (2015).
  • Hellman S , WeichselbaumRR. Oligometastases. J. Clin. Oncol.13(1), 8–10 (1995).
  • Van den Begin R , EngelsB, GevaertTet al. Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer. Radiother. Oncol.113(2), 235–239 (2014).
  • Lussier YA , XingHR, SalamaJKet al. MicroRNA expression characterizes oligometastasis(es). PLoS ONE6(12), e28650 (2011).
  • Niibe Y , ChangJY. Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm. Med.2012, 1–5 (2012).
  • Mönig S , van HootegemS, ChevallayM, WijnhovenBPL. The role of surgery in advanced disease for esophageal and junctional cancer. Best Pract. Res. Clin. Gastroenterol.36–37, 91–96 (2018).
  • Al-Batran S-E , HomannN, PauligkCet al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: The AIO-FLOT3 Trial. JAMA Oncol.3(9), 1237 (2017).
  • Chiapponi C , BerlthF, PlumPSet al. Oligometastatic disease in upper gastrointestinal cancer – how to proceed? Visc. Med. 33(1), 31–34 (2017).
  • Jung J , JungY, BangEJet al. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling. Ann. Surg. Oncol.21(S4), 736–742 (2014).
  • Polom K , BögerC, SmythEet al. Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency. Eur. J. Surg. Oncol.44(5), 626–631 (2018).
  • Ramos RF , ScalonFM, ScalonMM, DiasDI. Staging laparoscopy in gastric cancer to detect peritoneal metastases: a systematic review and meta-analysis. Eur. J. Surg. Oncol.42(9), 1315–1321 (2016).
  • deSouza NM , LiuY, ChitiAet al. Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European Organisation for Research and Treatment of Cancer Imaging Group. Eur. J. Cancer91, 153–163 (2018).
  • Rudloff U , LanganRC, MullinaxJEet al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial: gastric cancer multimodal therapy. J. Surg. Oncol.110(3), 275–284 (2014).
  • Ito H , TakemuraN, OnoYet al. Gastric cancer liver metastasis: optimal management for oligo-metastatic disease. J. Clin. Oncol.37(Suppl. 4), 136–136 (2019).
  • Grimes N , DevlinJ, DunneDFJ, PostonG, FenwickS, MalikH. The role of hepatectomy in the management of metastatic gastric adenocarcinoma: a systematic review. Surg. Oncol.23(4), 177–185 (2014).
  • Jung MK , OttK, ChevallayM, MönigSP. Therapieoptionen beim oligometastasierten Magenkarzinom. Chir.92(6), 515–521 (2021).
  • Al-Batran S-E , GoetzeTO, MuellerDWet al. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI. BMC Cancer17(1), 893 (2017).
  • Japanese Gastric Cancer Association . Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer24(1), 1–21 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.